产品中心Cell Resources
联系我们CONTACT US
- 400-999-210024小时服务热线
产品概述
名称 | LNCaP clone FGC (人前列腺癌细胞) (STR鉴定正确) |
别称 | LNCaP-Clone-FGC; LNCaP.FGC; LNCaP-FGC; LNCaP FGC; LNCaP-ATCC |
种属 | 人 |
生长特性 | 贴壁细胞 |
细胞形态 | 上皮细胞样 |
冻存条件 | 冻存液:55% 基础培养基+40%FBS+5%DMSO 温度:液氮 |
培养方案A(默认) |
培养条件:
气相:空气,95%;CO2,5%, 温度:37℃
|
推荐传代比例 | 1:3-1:4 |
推荐换液频率 | 2-3次/周 |
注意事项 | 1.该细胞并不形成一致的单层,而是形成集落。2.该细胞会使培养基快速变酸,且生长缓慢,故传代后 48 小时内不应扰动;3.普通TC处理的培养瓶或皿不能使细胞很好的贴壁,培养难度较高,需使用 Corning 的 cellbind 细胞培养瓶(货号是 3289),或者使用多聚-L-赖氨酸溶液(货号 PB180523)包被过的培养皿;4.在细胞运输途中,多数细胞会从培养瓶底分离,大片悬浮在培养基中,按照收货注意事项处理即可恢复正常。 |
背景描述 | 人前列腺癌细胞LNCaP clone FGC是从一位50岁白人男性(血型B+)的左锁骨淋巴结针刺活检中分离,该患者经确诊为前列腺癌转移。LNCaP clone FGC细胞对5-α-二氢睾酮(生长调节子和酸性磷酸脂酶产物)有响应。LNCaP clone FGC细胞并不形成一致的单层,而是形成集落,在传代时可以用滴管反复吹吸打碎。LNCaP clone FGC细胞仅仅轻轻地吸附在基底上,不形成汇合,很快使培养基变酸。LNCaP clone FGC细胞生长极其缓慢,传代后48小时内不应扰动。当培养瓶封包后,多数LNCaP clone FGC细胞从培养瓶底分离,悬浮在培养基中。收到后,在通常培养单层细胞的条件下培养24-48小时,以使细胞再贴壁。此后,可以换上新鲜培养液。如果需要,培养瓶内容物可以收集,300g离心15分钟,以10毫升培养液重悬并培养到一个单独的培养瓶中。 |
年龄(性别) | 男性;50岁 |
组织来源 | 前列腺;左锁骨淋巴结癌转移灶 |
细胞类型 | 肿瘤细胞 |
肿瘤类型 | 前列腺癌细胞 |
生物安全等级 | BSL-1 |
倍增时间 | ~32-36 hours |
致瘤性 | Yes, in soft agar.Yes, the cells are tumorigenic in nude mice. |
受体表达情况 | androgen receptor, positive;estrogen receptor, positive |
基因表达情况 | human prostatic acid phosphatase; prostate specific antigen |
保藏机构 | ATCC; CRL-1740 BCRC; 60088 BCRJ; 0149 ECACC; 89110211 |
STR鉴定
-
STR位点信息
Amelogenin X,Y CSF1PO 10,11 D2S1338 16 D3S1358 16 D5S818 11,12 D7S820 9.1,10.3 D8S1179 12,13,14 D13S317 10,12,13 D16S539 11 D18S51 11,12 D19S433 13.2,15 D21S11 29,32.2 FGA 19,20 PentaD 12,12.4 PentaE 12,16 TH01 9 TPOX 8,9 vWA 16,18 D6S1043 11,12,18 D12S391 21,22 D2S441 11.3 -
STR鉴定图
参考文献
-
Integrated analysis reveals FOXA1 and Ku70/Ku80 as targets of ivermectin in prostate cancer(2022/09/01)
作者:Shidong Lv, Zeyu Wu, Mayao Luo
期刊:Cell Death & Disease
DOI:10.1038/s41419-022-05182-0
影响因子 :9.000
-
Galaxolide and Irgacure 369 are novel environmental androgens(2023/03/09)
作者:Mingzhao Li, Ren Wang, Pan Wang
期刊:CHEMOSPHERE
DOI:10.1016/j.chemosphere.2023.138329
影响因子 :8.800
-
ATXN3 promotes prostate cancer progression by stabilizing YAP(2023/06/22)
作者:Longxiang Wu, Zhenyu Ou, Peihua Liu
期刊:Cell Communication and Signaling
DOI:10.1186/s12964-023-01073-9
影响因子 :8.400
-
PEG-coated and Gd-loaded fluorescent silica nanoparticles for targeted prostate cancer magnetic resonance imaging and fluorescence imaging(2023/01/02)
作者:Wei Jiang, Huiying Fang, Fengqiu Liu
期刊:International Journal of Nanomedicine
影响因子 :8.000
引用产品:CL-0143
-
ND630 controls ACACA and lipid reprogramming in prostate cancer by regulating the expression of circKIF18B_003(2023/12/04)
作者:Yupeng Wu, Wencai Zheng, Qi Huang
期刊:Journal of Translational Medicine
DOI:10.1186/s12967-023-04760-w
影响因子 :7.400
引用产品:CL-0143
-
Tautomycin and enzalutamide combination yields synergistic effects on castration-resistant prostate cancer(2022/11/29)
作者:Luo, Mayao, Zhang, Yifan, Xu, Zhuofan, Wu, Chenwei, Ye, Yuedian, Liu, Rui, Lv, Shidong, Wei, Qiang
期刊:Cell Death Discovery
DOI:10.1038/s41420-022-01257-1
影响因子 :7.000
-
Triggering pyroptosis enhances the antitumor efficacy of PARP inhibitors in prostate cancer(2023/08/23)
作者:Ao Tian, Tingyu Wu, Yanshuang Zhang
期刊:CELLULAR ONCOLOGY
DOI:10.1007/s13402-023-00860-3
影响因子 :6.600
-
β-hydroxybutyrate inhibits malignant phenotypes of prostate cancer cells through β-hydroxybutyrylation of indoleacetamide-N-methyltransferase(2024/03/30)
作者:Yifan Zhang, Yunlong Li
期刊:Cancer Cell International
DOI:10.1186/s12935-024-03277-6
影响因子 :5.800
引用产品:CL-0143
-
AID-induced CXCL12 upregulation enhances castration-resistant prostate cancer cell metastasis by stabilizing β-catenin expression(2023/11/23)
作者:Qi Li, Jinfeng Fan, Zhiyan Zhou
期刊:iScience
DOI:10.1016/j.isci.2023.108523
影响因子 :5.800
引用产品:CL-0143
-
LOC100996425 acts as a promoter in prostate cancer by mediating hepatocyte nuclear factor 4A and the AMPK/mTOR pathway(2021/08/19)
作者:Xiuyan Wang, Bin Song, Mingcui Zang
期刊:Journal Of Cellular And Molecular Medicine
影响因子 :5.300
-
MET inhibition enhances PARP inhibitor efficacy in castration-resistant prostate cancer by suppressing the ATM/ATR and PI3K/AKT pathways(2021/11/10)
作者:Sihai Zhou, Zhihong Dai, Liang Wang
期刊:Journal Of Cellular And Molecular Medicine
影响因子 :5.295
-
Cuproptosis enhances docetaxel chemosensitivity by inhibiting autophagy via the DLAT/mTOR pathway in prostate cancer(2023/08/16)
作者:Hongzhuang Wen, Changbao Qu, Zhu Wang
期刊:FASEB JOURNAL
影响因子 :4.800
-
Comprehensiveness cuproptosis related genes study for prognosis and medication sensitiveness across cancers, and validation in prostate cancer(2024/04/26)
作者:Longfei Yang, Yifan Tang, Yuwei Zhang
期刊:Scientific Reports
DOI:10.1038/s41598-024-57303-8
影响因子 :4.600
引用产品:CL-0143
-
HMGB1 promotes the development of castration‑resistant prostate cancer by regulating androgen receptor activation(2022/09/19)
作者:Junyu Chen, Duo Xu, Taiwei Wang
期刊:ONCOLOGY REPORTS
影响因子 :4.200
-
PLA inhibits TNF-α-induced PANoptosis of prostate cancer cells through metabolic reprogramming(2024/02/24)
作者:Yinghui Hao, Fangmei Xie, Jieyi He
期刊:INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
DOI:10.1016/j.biocel.2024.106554
影响因子 :4.000
引用产品:CL-0143
-
Analyzing roles of small nucleolar RNA host gene 25 from clinical, molecular target and tumor formation in prostate cancer(2023/06/10)
作者:Zelin Liu, Shuai Ke, Qinghua Wang
期刊:EXPERIMENTAL CELL RESEARCH
DOI:10.1016/j.yexcr.2023.113686
影响因子 :3.700
-
A cuproptosis-related LncRNA signature: Integrated analysis associated with biochemical recurrence and immune landscape in prostate cancer(2023/02/24)
作者:Lei Ren, Xu Yang, Weifeng Wang
期刊:Frontiers in Genetics
DOI:10.3389/fgene.2023.1096783
影响因子 :3.700
-
A Prognostic Model for Prostate Cancer Patients Based on Two DNA Damage Response Mutation-Related Immune Genes(2023/08/22)
作者:Jian Wang, Li Jiang, Zhenhua Shang
期刊:CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS
影响因子 :3.400
-
IU1 and enzalutamide combination yields synergistic effects on castration-resistant prostate cancer(2023/08/07)
作者:Yifan Zhang, Yuanpeng Liao, Mayao Luo
期刊:PROSTATE
影响因子 :2.800
-
GPX2 predicts recurrence-free survival and triggers the Wnt/β-catenin/EMT pathway in prostate cancer(2022/10/25)
作者:Ming Yang, Xudong Zhu, Yang Shen
期刊:PeerJ
影响因子 :2.700
-
Exploring the role of differentially expressed metabolic genes and their mechanisms in bone metastatic prostate cancer(2023/04/12)
作者:Qingfu Zhang, Peng Zhang, Zhongting Zhao
期刊:PeerJ
影响因子 :2.700
-
Circ_0044516 Enriches the Level of SARM1 as a miR-330-5p Sponge to Regulate Cell Malignant Behaviors and Tumorigenesis of Prostate Cancer(2022/01/07)
作者:Yan Wu
期刊:Biochemical Genetics
DOI:10.1007/s10528-021-10160-w
影响因子 :2.400
-
A morpholine derivative N-(4-morpholinomethylene)ethanesulfonamide induces ferroptosis in tumor cells by targeting NRF2(2024/01/30)
作者:Bingchun Sun, Ligang Zhang, Binhua Wu
期刊:BIOLOGICAL & PHARMACEUTICAL BULLETIN
影响因子 :2.000
引用产品:CL-0143
FAQs
Q:{{item.question}}
A:{{item.answer}}
产品资料
识别码示意图